Prospective surveillance study of acute respiratory infections, influenza-like illness and seasonal influenza vaccine in a cohort of juvenile idiopathic arthritis patients

Luciana M Carvalho, Flávia E de Paula, Rodrigo V D Silvestre, Luciana R Roberti, Eurico Arruda, Wyller A Mello, Virginia P L Ferriani, Luciana M Carvalho, Flávia E de Paula, Rodrigo V D Silvestre, Luciana R Roberti, Eurico Arruda, Wyller A Mello, Virginia P L Ferriani

Abstract

Background: Acute respiratory infections (ARI) are frequent in children and complications can occur in patients with chronic diseases. We evaluated the frequency and impact of ARI and influenza-like illness (ILI) episodes on disease activity, and the immunogenicity and safety of influenza vaccine in a cohort of juvenile idiopathic arthritis (JIA) patients.

Methods: SURVEILLANCE OF RESPIRATORY VIRUSES WAS CONDUCTED IN JIA PATIENTS DURING ARI SEASON (MARCH TO AUGUST) IN TWO CONSECUTIVE YEARS: 2007 (61 patients) and 2008 (63 patients). Patients with ARI or ILI had respiratory samples collected for virus detection by real time PCR. In 2008, 44 patients were immunized with influenza vaccine. JIA activity index (ACRPed30) was assessed during both surveillance periods. Influenza hemagglutination inhibition antibody titers were measured before and 30-40 days after vaccination.

Results: During the study period 105 ARI episodes were reported and 26.6% of them were ILI. Of 33 samples collected, 60% were positive for at least one virus. Influenza and rhinovirus were the most frequently detected, in 30% of the samples. Of the 50 JIA flares observed, 20% were temporally associated to ARI. Influenza seroprotection rates were higher than 70% (91-100%) for all strains, and seroconversion rates exceeded 40% (74-93%). In general, response to influenza vaccine was not influenced by therapy or disease activity, but patients using anti-TNF alpha drugs presented lower seroconversion to H1N1 strain. No significant differences were found in ACRPed30 after vaccination and no patient reported ILI for 6 months after vaccination.

Conclusion: ARI episodes are relatively frequent in JIA patients and may have a role triggering JIA flares. Trivalent split influenza vaccine seems to be immunogenic and safe in JIA patients.

Keywords: Acute respiratory infections; Influenza vaccine; Influenza-like illness; Juvenile idiopathic arthritis; Respiratory viruses.

Figures

Figure 1
Figure 1
Study time-table describing surveillance for viral respiratory infections, influenza vaccination and follow-up after vaccination period. *Surveillance for upper respiratory viruses occurred during two subsequent years, from March to August: 2007- surveillance 1; and 2008 – surveillance 2. ** Influenza vaccine was offered between April and July 2008, during the surveillance 2 period. # Follow-up after vaccination: period of six months after the vaccine. n = number of patients included in each period.

References

    1. Estratégia de Vacinação contra Influenza Pandêmica (H1N1) e Influenza Sazonal. 2009. .
    1. Smith NM, Bresee JS, Shay DK, Uyeki TM, Cox NJ, Strikas RA. Prevention and control of influenza: recommendations of the advisory committee on immunization practices (ACIP) MMWR Recomm Rep. 2006;55:1–42.
    1. Bruck N, Gahr M, Pessler F. Transient oligoarthritis of the lower extremity following influenza B virus infection: Case report. Pediatr Rheumatol. 2010;8 Retrieved from Pediatric Rheumatology website: .
    1. Pritchard MH, Matthews N, Munro J. Antibodies to influenza A in a cluster of children with juvenile chronic arthritis. Br J Rheumatol. 1988;27:176–180. doi: 10.1093/rheumatology/27.3.176.
    1. Kanakoudi-Tsakalidou F, Trachana M, Pratsidou-Gertsi P, Tsitsami E, Kyriazopoulou-Dalaina V. Influenza vaccination in children with chronic rheumatic diseases and long-term immunosuppressive therapy. Clin Exp Rheumatol. 2001;19:589–594. doi: 10.1007/s100510170304.
    1. Malleson PN, Tekano JL, Scheifele DW, Weber JM. Influenza immunization in children with chronic arthritis: a prospective study. J Rheumatol. 1993;20:1769–1773.
    1. Olson NY, Lindsley CB. Influenza immunization in children with chronic arthritis. J Rheumatol. 1994;21:1581–1582.
    1. Ogimi C, Tanaka R, Saitoh A, Oh-Ishi T. Immunogenicity of influenza vaccine in children with pediatric rheumatic diseases receiving immunosuppressive agents. Pediatr Infect Dis J. 2010;30:208–211.
    1. Aikawa NE, Campos LM, Silva CA, Carvalho JF, Saad CG, Trudes G, Duarte A, Miraglia JL, Timenetsky MD, Viana VS. Glucocorticoid: major factor for reduced immunogenicity of 2009 influenza a (H1N1) vaccine in patients with juvenile autoimmune rheumatic disease. J Rheumatol. 2011;39:167–173.
    1. Dell’Era L, Corona F, Daleno C, Scala A, Principi N, Esposito S. Immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis. Vaccine. 2012;30:936–940. doi: 10.1016/j.vaccine.2011.11.083.
    1. Shinoki T, Hara R, Kaneko U, Miyamae T, Imagawa T, Mori M, Yokota S. Safety and response to influenza vaccine in patients with systemic-onset juvenile idiopathic arthritis receiving tocilizumab. Mod Rheumatol. 2012;22:871–876. doi: 10.1007/s10165-012-0595-z.
    1. Toplak N, Subelj V, Kveder T, Cucnik S, Prosenc K, Trampus-Bakija A, Todorovski L, Avcin T. Safety and efficacy of influenza vaccination in a prospective longitudinal study of 31 children with juvenile idiopathic arthritis. Clin Exp Rheumatol. 2012;30:436–444.
    1. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390–392.
    1. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum. 1997;40:1202–1209.
    1. Brunner HI, Lovell DJ, Finck BK, Giannini EH. Preliminary definition of disease flare in juvenile rheumatoid arthritis. J Rheumatol. 2002;29:1058–1064.
    1. Wallace CA, Ruperto N, Giannini E. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol. 2004;31:2290–2294.
    1. Bellei N, Carraro E, Perosa A, Watanabe A, Arruda E, Granato C. Acute respiratory infection and influenza-like illness viral etiologies in Brazilian adults. J Med Virol. 2008;80:1824–1827. doi: 10.1002/jmv.21295.
    1. Souza LS, Ramos EA, Carvalho FM, Guedes VM, Rocha CM, Soares AB, Velloso Lde F, Macedo IS, Moura FE, Siqueira M. Viral respiratory infections in young children attending day care in urban Northeast Brazil. Pediatr Pulmonol. 2003;35:184–191. doi: 10.1002/ppul.10194.
    1. Ministry of Health. National laboratory guidelines for pandemic influenza: collection and handling of human specimens for laboratory diagnosis of influenza with pandemic potential. City: Minstry of Health; 2006. (Book national laboratory guidelines for pandemic influenza: collection and handling of human specimens for laboratory diagnosis of influenza with pandemic potential). Editor ed.^eds.
    1. Lambert SB, Allen KM, Druce JD, Birch CJ, Mackay IM, Carlin JB, Carapetis JR, Sloots TP, Nissen MD, Nolan TM. Community epidemiology of human metapneumovirus, human coronavirus NL63, and other respiratory viruses in healthy preschool-aged children using parent-collected specimens. Pediatrics. 2007;120:e929–e937. doi: 10.1542/peds.2006-3703.
    1. Deffernez C, Wunderli W, Thomas Y, Yerly S, Perrin L, Kaiser L. Amplicon sequencing and improved detection of human rhinovirus in respiratory samples. J Clin Microbiol. 2004;42:3212–3218. doi: 10.1128/JCM.42.7.3212-3218.2004.
    1. Garbino J, Gerbase MW, Wunderli W, Deffernez C, Thomas Y, Rochat T, Ninet B, Schrenzel J, Yerly S, Perrin L. Lower respiratory viral illnesses: improved diagnosis by molecular methods and clinical impact. Am J Respir Crit Care Med. 2004;170:1197–1203. doi: 10.1164/rccm.200406-781OC.
    1. Heim A, Ebnet C, Harste G, Pring-Akerblom P. Rapid and quantitative detection of human adenovirus DNA by real-time PCR. J Med Virol. 2003;70:228–239. doi: 10.1002/jmv.10382.
    1. Hu A, Colella M, Tam JS, Rappaport R, Cheng SM. Simultaneous detection, subgrouping, and quantitation of respiratory syncytial virus A and B by real-time PCR. J Clin Microbiol. 2003;41:149–154. doi: 10.1128/JCM.41.1.149-154.2003.
    1. Kuypers J, Martin ET, Heugel J, Wright N, Morrow R, Englund JA. Clinical disease in children associated with newly described coronavirus subtypes. Pediatrics. 2007;119:e70–e76. doi: 10.1542/peds.2006-1406.
    1. Kuypers J, Wright N, Corey L, Morrow R. Detection and quantification of human metapneumovirus in pediatric specimens by real-time RT-PCR. J Clin Virol. 2005;33:299–305. doi: 10.1016/j.jcv.2004.11.023.
    1. Kuypers J, Wright N, Ferrenberg J, Huang ML, Cent A, Corey L, Morrow R. Comparison of real-time PCR assays with fluorescent-antibody assays for diagnosis of respiratory virus infections in children. J Clin Microbiol. 2006;44:2382–2388. doi: 10.1128/JCM.00216-06.
    1. Neske F, Blessing K, Tollmann F, Schubert J, Rethwilm A, Kreth HW, Weissbrich B. Real-time PCR for diagnosis of human bocavirus infections and phylogenetic analysis. J Clin Microbiol. 2007;45:2116–2122. doi: 10.1128/JCM.00027-07.
    1. Nystrom K, Biller M, Grahn A, Lindh M, Larson G, Olofsson S. Real time PCR for monitoring regulation of host gene expression in herpes simplex virus type 1-infected human diploid cells. J Virol Methods. 2004;118:83–94. doi: 10.1016/j.jviromet.2004.01.019.
    1. van Elden LJ, Nijhuis M, Schipper P, Schuurman R, van Loon AM. Simultaneous detection of influenza viruses A and B using real-time quantitative PCR. J Clin Microbiol. 2001;39:196–200. doi: 10.1128/JCM.39.1.196-200.2001.
    1. Influenza virus vaccine 2008-2009 season. .
    1. American Academy of Pediatrics Committee on Infectious Diseases. Recommendations for influenza immunization of children. Pediatrics. 2004;113:1441–1447.
    1. WHO Collaborating Center for the surveillance eacoI. The 2006-2007 WHO Influenza reagent KIT for identification of Influenza isolates. City: CDC Influenza Division; 2006. (Book The 2006-2007 WHO Influenza reagent KIT for identification of Influenza isolates). Editor ed.^eds.
    1. Committee for Proprietary Medicinal Products. Note for guidance on clinical evaluation of new vaccines. CPMP/EWP/463/97. may 1999. City: European Agency for the Evaluation of Medicinal Products (EMEA); 1999. (Book Note for guidance on clinical evaluation of new vaccines. CPMP/EWP/463/97). Editor ed.^eds.
    1. Committee for Proprietary Medicinal Products. Note for guidance on harmonisation of requirements for influenza vaccines. CPMP/BWP/214/96. March 1997. City: European Agengy for the Evaluation of Medicinal Products (EMEA); 1997. (Book Note for guidance on harmonisation of requirements for influenza vaccines. CPMP/BWP/214/96). (Editor ed.^eds.
    1. Mazin SC, Oliveira MS, Martinez EZ, Achcar JA, Ramos SG. Uso de um modelo Bayesiano de Poisson com excesso de zeros na análise de dados de lesões miocárdicas em recém-nascidos com cardiopatias congênitas complexas. Revista Brasileira de Biometria. 2008;26:12.
    1. Graham NM. The epidemiology of acute respiratory infections in children and adults: a global perspective. Epidemiol Rev. 1990;12:149–178.
    1. Proenca-Modena JL, Acrani GO, Snider GL, Arruda E. In: Tropical infectious diseases - principles, pathogens & practice. Third edition. Gerrant RL, Walker DH, Weller PF, editor. Philadelphia: Churchill Livingstone; 2011. Respiratory viruses: influenza virus, respiratory syncytial virus, human metapneumovirus, parainfluenza viruses, rhinovirus, respiratory adenoviruses, Coronaviruses (unrelated to SARS) and human bocavirus.
    1. Albuquerque MC, Pena GP, Varella RB, Gallucci G, Erdman D, Santos N. Novel respiratory virus infections in children, Brazil. Emerg Infect Dis. 2009;15:806–808. doi: 10.3201/eid1505.081603.
    1. Gagliardi TB, Iwamoto MA, Paula FE, Proenca-Modena JL, Saranzo AM, Criado MF, Acrani GO, Camara AA, Cintra OA, Arruda E. Human bocavirus respiratory infections in children. Epidemiol Infect. 2009;137:1032–1036. doi: 10.1017/S0950268808001842.
    1. Thomazelli LM, Vieira S, Leal AL, Sousa TS, Oliveira DB, Golono MA, Gillio AE, Klaus ES, Erdman DD, Durigon EL. Surveillance of eight respiratory viruses in clinical samples of pediatric patients in Southeast Brazil. J Pediatr (Rio J) 2007;83:6.
    1. Koskenvuo M, Mottonen M, Rahiala J, Saarinen-Pihkala UM, Riikonen P, Waris M, Ziegler T, Uhari M, Salmi TT, Ruuskanen O. Respiratory viral infections in children with leukemia. Pediatr Infect Dis J. 2008;27:974–980. doi: 10.1097/INF.0b013e31817b0799.
    1. van Ewijk BE, van der Zalm MM, Wolfs TF, Fleer A, Kimpen JL, Wilbrink B, van der Ent CK. Prevalence and impact of respiratory viral infections in young children with cystic fibrosis: prospective cohort study. Pediatrics. 2008;122:1171–1176. doi: 10.1542/peds.2007-3139.
    1. Lu Y, Jacobson DL, Ashworth LA, Grand RJ, Meyer AL, McNeal MM, Gregas MC, Burchett SK, Bousvaros A. Immune response to influenza vaccine in children with inflammatory bowel disease. Am J Gastroenterol. 2009;104:444–453. doi: 10.1038/ajg.2008.120.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren